+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
From
Bioengineered Protein Drugs Global Market Report 2024 - Product Thumbnail Image

Bioengineered Protein Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 179 Pages
  • Global
From
mRNA Therapeutics and Vaccines Market, 2020-2030 - Product Thumbnail Image

mRNA Therapeutics and Vaccines Market, 2020-2030

  • Report
  • January 2021
  • 253 Pages
  • Global
From
From
From
Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 93 Pages
  • Global
From
Global Microneedle Flu Vaccine Market - Product Thumbnail Image

Global Microneedle Flu Vaccine Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Fertility Drugs Global Market Report 2024 - Product Thumbnail Image

Fertility Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Loading Indicator